PCDH15 and Familial prostate cancer: We find that mutations in the TP53, FLT4, EYA1, NCOR2, CSMD3, and PCDH15 genes are associated with prostate cancer metastasis and mutations in EYA1 and CSMD3 are associated with poor outcome.